David C. Duffy, Ph.D.

team-member-details

David C. Duffy, Ph.D.

Entrepreneur in Residence

David is an entrepreneurial scientist who has devoted his career to the development of bioanalytical technologies and products for life science research and clinical diagnostics. He has worked to translate novel, enabling technologies from academia into start-ups, and built these companies to initial commercialization and beyond. David most recently served as CTO at Quanterix Corporation having joined the company as its second employee in 2007. At Quanterix, he led the development of the single molecule array (Simoa) technology and products that catalyzed the field of blood-based diagnosis of neurological diseases, such as Alzheimer’s disease. Prior to Quanterix, he worked as a scientist at Surface Logix, Gamera Biosciences, and Unilever.

David has published more than 50 papers in the fields of microfluidics, surface chemistry, single-molecule detection, and proteomics, and is an inventor on 36 US patents. In 2023, he received the Daniel Perlman Memorial Award from the American Chemical Society for his role in establishing the field of digital immunoassays. David was a post-doctoral research fellow in the Department of Chemistry and Chemical Biology at Harvard University, and was the first Sir Alan Wilson Research Fellow of Emmanuel College at the University of Cambridge. He received his Ph.D. in Physical Chemistry from the University of Cambridge, and earned his M.A. and B.A. degrees in Natural Sciences from Selwyn College at the University of Cambridge.